COPPELL, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), the leading developer and provider of nutritional supplements and skin care products based on Real Food Technology® solutions, officially opened office headquarters last Saturday in four new countries across central and eastern Europe, including the Czech Republic, Estonia, Finland and the Republic of Ireland. The openings bring Mannatech’s global presence to 21 countries, including Canada, England, Japan, Mexico, South Africa and South Korea.
“Since 1994, we have supported hard-working people looking to improve their lives through healthy living and entrepreneurial opportunities,” said Dr. Robert Sinnott, co-CEO and chief science officer of Mannatech. “We have found that millions of Europeans share this same passion for changing lives through proven wellness products and a profitable home-based business, so further expansion into Europe is a perfect fit for all of us.”
Mannatech has distinguished itself in the emerging glyconutrient market through the scientific development of its proprietary Ambrotose® complex. This technology holds more than 48 patents in 30 countries around the world. Many of Mannatech’s products, including Ambrotose, are based on Real Food Technology solutions, which provide consumers with products that contain standardized levels of natural and plant-sourced nutrients.
Al Bala, executive vice president of sales suggests the addition of these four strategic markets sets the stage for potential future expansion into Central and Eastern Europe.
“According to the Direct Selling Association, there are currently more than 340,000 individuals living in these countries already involved in direct sales, creating €230 million ($335 million USD) in annual revenue,” he said. “No one offers the science we do. Add to that our commitment to social entrepreneurship and an integrative health platform, and it is obvious that Mannatech provides any entrepreneur with vision a dynamic opportunity to make a difference.”
Individuals interested in Mannatech’s products or exploring its business opportunity can learn more at Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurism based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, the Republic of Korea and Mexico. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.